Statistics for Organogenesis Holdings (id:5421 ORGO)

Valuation metrics

Market cap

522.35M

Enterprise value

525.07M

Trailing P/E (ttm)

62.38

Forward P/E

-98.50

PEG ratio

-98.50

Price/Sales (ttm)

1.15

Price/Book (mrq)

1.88

Enterprise Value/Revenue

1.15

Enterprise Value/EBITDA

18.27

Overview

Shares outstanding

132.58M

Float

59.76M

Shares short

9.79M

% Held by insiders

0.41%

% Held by institutions

0.48%

Average volume (10 days)

873.76K

Average volume (90 days)

Price summary

52-Week low

2.16

52-Week high

4.70

52-Week change

34.76%

Beta

1.60

50-Day moving average

3.02

200-Day moving average

2.89

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-1.62%

Operating margin

5.42%

Operational effectiveness

Return on assets

1.64%

Return on equity

-2.66%

Income statement

Revenue (ttm)

3.45

Revenue per share (ttm)

3.45

Quarterly revenue growth (yoy)

2.89

Gross profit (ttm)

326.66M

EBITDA

34.92M

Net income to common (ttm)

-7,380,000.00

Diluted EPS (ttm)

-0.12

Quarterly earnings growth (yoy)

289.40%

Balance sheet

Total cash (mrq)

94.34M

Total cash per share (mrq)

0.71

Total debt (mrq)

107.67M

Total Debt/Equity (mrq)

38.65

Current ratio (mrq)

308.60%

Book value per share (mrq)

2.10

Cash flow

Cash flow statement

13.88M

Levered free cash flow (LFCF)

13.47M